Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Josh Gad reveals he had to stop taking weight-loss drug due to side effects: ‘Really bummed out’
The actor said he lost 40 pounds taking GLP-1 medication before a negative side effect necessitated a change to a different drug.
Can weight loss drugs like Ozempic treat obesity in children?
GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger people? Katharine Lang reports Obesity in children and adolescents is a growing problem.
The Health Risks and Benefits of Weight-Loss Drugs
The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing weight. In report published in Nature Medicine,
Josh Gad Reveals He’s Lost 40-Lbs. After Taking Weight Loss Medication
Frozen’s Josh Gad shared insight into his weight loss journey after losing 40 pounds with the help of medication.
Josh Gad Makes Bold Declaration About Weight Loss Drugs After Losing 40 Pounds
Josh Gad is the latest celebrity to talk about using a weight loss medication—and while his experience has been positive, he does have some doubts about his transformation. “I’m on a GLP-1...this is the first time I’ve opened up about this,
Josh Gad Has Lost 40 Lbs on GLP-1 Medication: 'It Is a Miracle Drug'
Josh Gad is opening up about the weight loss success he's had with GLP-1 medication - and sharing some of the conflicted feelings he's had along the way. "I'm on a GLP-1 … this is the first time I've opened up about this,
Josh Gad credits 'miracle drug' with helping him lose 40 pounds
During an interview for the Armchair Expert podcast on Monday, the actor revealed that he has been taking a GLP-1 medication for weight loss. "I'm on a GLP-1... this is the first time I've opened up about this,
Healio
12h
Top in endocrinology: Notable weight loss with next-gen GLP-1; erectile dysfunction risk
Amycretin, a novel once-weekly subcutaneous GLP-1 and amylin receptor agonist, was safe compared with other incretin-based ...
1d
Ozempic vs. Semaglutide: 10 Weight Loss Medications Compared for 2025
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
Medscape
16h
GLP-1 for Complex Cases: Breakthrough Therapies That Transform Patient Care
Unlock the potential of GLP-1 therapies! Join experts to explore cutting-edge strategies for managing cardiovascular & ...
1d
Oprah Winfrey shares the type of weight loss medication she took
Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...
Medical News Today
8d
GLP-1 drugs linked to lower dementia risk, higher risk of kidney, stomach issues
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
IPWatchdog
1d
The Growing Market for Weight Loss Treatments: Innovation, Patents, and the Future of GLP-1 Agonists
In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...
Hosted on MSN
7h
Lighter but weaker? The hidden costs of Ozempic and weight-loss drugs for endurance athletes
Ozempic and other semaglutide medications have skyrocketed in popularity as weight-loss aids, with prescriptions surging by ...
2d
on MSN
RFK Jr, Dr Oz and weight-loss drugs: A high-price health clash may be looming
Its weight-loss drug policy would fall to Trump's pick for health secretary, Robert F Kennedy Jr, and Mehmet Oz, Trump's ...
Rolling Out
2d
Revolutionizing addiction treatment with GLP-1 agonists
Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.
Barchart on MSN
1d
This Little-Known Stock Just Doubled on Weight-Loss Drug News. Analysts Think It Has 400% Upside Potential From Here.
Growing demand for weight-loss solutions has catapulted pharmaceutical firms like Eli Lilly (LLY) and Novo Nordisk (NVO) into ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback